510(k) Report

510(k) · Cleared

Cleared

Wavestate Neuromonitor

K092625510(k) TraditionalCleared Jun 29, 2010306-day reviewClass II21 CFR 882.1400

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Wavestate, Inc. · ORT Burst Suppression Detection Software For Electroencephalograph

Cleared on Jun 29, 2010 as substantially equivalent to K021185 (Taugagreining HF, 2002) and 2 other predicates after a 306-day review. Its family tree reaches back 2 generations to 1997.

Decided
Jun 29, 2010
Review
306 days
Class
Class II
Product code
ORT
Recalls
None
Predicates
3

Its longest line of descent runs back 2 generations to K964280 (1997). 5 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2002: 1 other ancestor2001: 1 other ancestor1999: 1 other ancestorK964280 · DG Nervus · Medelec, Ltd. · 1997 · recalledK061908 · Nicoletone System V32 Amplifier · Viasys Neuro Care · 20061995200020052010
Other ancestors, by generation 1 generation back: 2 other ancestors2 generations back: 1 other ancestor K061908 · Nicoletone System V32 Amplifier · Viasys Neuro Care · 2006K964280 · DG Nervus · Medelec, Ltd. · 1997 · recalled0
  1. Root · 2 generations backK964280 DG NervusMedelec, Ltd. · 1997 · Recalled
  2. 1 generation backK061908 Nicoletone System V32 AmplifierViasys Neuro Care · 2006
  3. This deviceK092625 Wavestate NeuromonitorWavestate, Inc. · 2010
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K964280DG NervusMedelec, Ltd.19971
−1K061908Nicoletone System V32 AmplifierViasys Neuro Care2006—
0 (this device)K092625Wavestate NeuromonitorWavestate, Inc.2010—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199910
200110
200210
FIG. 1 — Lineage of K092625, 1997–2010Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in ORT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K021185Nervus Monitor
Summary page 1
…keted Equivalent Device Company Product 510(k)# Taugagreining HF Nervus Monitor K021 185 Viasys NeuroCare, Inc. NicoletOne System V32 K061908 Lifelines Ltd. Lifelines Trac…
Taugagreining HF20022
*K061908Nicoletone System V32 Amplifier
Summary page 1
…510(k)# Taugagreining HF Nervus Monitor K021 185 Viasys NeuroCare, Inc. NicoletOne System V32 K061908 Lifelines Ltd. Lifelines Trackit K010460 DEVICE DESCRIPTION…
Viasys Neuro Care2006—
*K010460Lifelines Trackit
Summary page 1
…K021 185 Viasys NeuroCare, Inc. NicoletOne System V32 K061908 Lifelines Ltd. Lifelines Trackit K010460 DEVICE DESCRIPTION 807.92(a)(4) Wavestate, Inc. has created a new application for the…
Lifelines, Ltd.2001—

Also cleared against K021185: 5 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 13 years and passes through 3 companies; a new generation was cleared every 9.8 years on median.
  • 2 of the 5 ancestors have a recall of any class.
  • 5 other devices also cite its predicate K021185.

How does its category compare?

All ORT devices

ORT Burst Suppression Detection Software For Electroencephalograph: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · ORT

1in 2010

2010: 1
2007high 1 (2010) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · ORT

Too few ORT 510(k)s in any year since 2007 to give a median.

Recalls per year · ORT

No recall names ORT since 2007.

Adverse event reports per year · ORT

1in 2025

2017: 12025: 1
2007high 1 (2017) · low 0 (2007)2025

MAUDE reports naming product code ORT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20101—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—01
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—01
20260—0—

What is it indicated for?

The Wavestate Neuromonitor System is intended to collect, record, and store Lip to 24 channels of adult EEG data for up to 24 hours. The System also can perform a post review of adult BEG data and identify burst suppression pattern in the stored BEG. The device displays the mean interburst interval reviewed up to that time point and the probability that the displayed value is within +1-2 seconds of the mean of the interburst intervals for the entire…

Read the full statement (117 words)

The Wavestate Neuromonitor System is intended to collect, record, and store Lip to 24 channels of adult EEG data for up to 24 hours. The System also can perform a post review of adult BEG data and identify burst suppression pattern in the stored BEG. The device displays the mean interburst interval reviewed up to that time point and the probability that the displayed value is within +1-2 seconds of the mean of the interburst intervals for the entire dataset for that patient. The Wavestate Neuromnonitor System does not provide any diagnostic conclusion about the patient's condition to the user. The Wavestate Neuromonitor is to be used under the guidance and interpretation of a licensed medical practitioner.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K092625: Wavestate Neuromonitor.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K092625

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026